## Abstract We report here a case of blastic natural killer (NK)โcell lymphoma treated successfully with autologous peripheral blood stemโcell transplantation (APBSCT). A 57โyearโold man had skin tumors and was diagnosed as having blastic NKโcell lymphoma by tumor biopsy. Skin, lymph nodes, left to
Determinants of peripheral blood count value in long-term survivors of allogeneic hemopoietic stem cell transplantation
โ Scribed by Paul A Koljonen; Albert Kwok-wai Lie; Raymond Liang; Wing-Yan Au
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 98 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0278-0232
- DOI
- 10.1002/hon.885
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Hemopoeitic stem cell transplant (HSCT) recipients are monitored by regular complete blood picture (CBP). The reference ranges for acceptable values are undefined. We analysed the CBP in 228 stable HSCT survivors (median followโup 103 months, range 60โ212) without transplantโrelated medications and complications. Compared with donors, recipients had lower absolute neutrophil count (ANC) and platelet levels (Plt) and higher mean corpuscular volume (MCV), but comparable hemoglobin (Hb) and absolute lymphocyte count (ALC). There was significant donorโrecipient correlation in all CBP parameters (Hb, ALC, ANC, MCV, Plt). Significant correlation was also found between levels of Hb, white cell and Plt among recipients. All counts were higher in patients with longer followโup. Donor and recipient gender, age and underlying diagnosis can influence stable CBP values. We conclude that both host and marrow factors influence CBP values in stably engrafted recipients. โAbnormalโ CBP values deviating from that in normal populations may not have clinical significance. Copyright ยฉ 2009 John Wiley & Sons, Ltd.
๐ SIMILAR VOLUMES
Survivors of allogeneic marrow transplants are immunodeficient for at least 1 year after grafting. Multiple defects of immunity have been found; however, it is not known which defect primarily accounts for the high infectious morbidity of these patients. Twenty-nine allograft recipients who were in
It has been shown that after allogeneic peripheral blood stem cell transplantation (PBSCT), donor T cells can induce potent graft-versus-tumor (GVT) effects in hematologic malignancies and possibly solid tumors such as renal cell carcinoma. Two patients (27 and 30 years old) with metastatic melanoma